Studies in rectal, renal cell and cervical cancer, as well as in malignant melanoma have proposed that CD8+Ki67+ Tlymphocytes may be prognostically relevant in rectal and RCC but not in cervical cancer and malignant melanoma [14, 16, 22, 23]. This evidence concerns the gene MKI67 and renal cell adenocarcinoma.